Cristobal Belda-Iniesta

Hospital Universitario HM Sanchinarro

Disclosure: NO DISCLOSURE DATA

Presentation(s):

• ACTR-33 - Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II study

  Saturday, November 23
  5:00 PM – 7:00 PM